Children Underrepresented in Clinical Drug Trials: Study October 01, 2012.

When drugs are tested only in adults, kids and their doctors are at a disadvantage, researchers say.

MONDAY, Oct. 1 (HealthDay News) — Drug studies enrolling adults far outnumber clinical trials involving children, and the scope of research on children is also more limited than it is for adults, new research from Duke University finds.

This puts children and their physicians at a significant disadvantage, the researchers concluded.

“Although children comprise one-quarter of the population in the United States, they are greatly underrepresented in the clinical trial process that is designed to lead to new and better therapies, determine appropriate drug dosages and establish standards of practice,” said study first author Dr. Sara Pasquali, who is now co-director of the Michigan Congenital Heart Outcomes Research and Discovery Program at the University of Michigan in Ann Arbor. Read more